Comment

  • 29 August 2019

    TAVI procedure volume poised to spike

    Transcatheter aortic valve implantation (TAVI) is a relatively new procedure for the minimally invasive replacement of a patient’s aortic valve. In recent years, TAVI has exploded as an extremely successful...

  • 27 August 2019

    Bayer AG acquires BlueRock Therapeutics

    Bayer announced on August 8 that it had entered an agreement to fully acquire BlueRock Therapeutics, a biotechnology company focused on cellular therapy development.

Close
Close
Close